Showing results (2501-2510 of 3,061) with videos related to

Sort By:
Pageof 307
Surgical Endoscopy|May 3, 2013
Endoscopic ultrasound (EUS)-guided fiducial placement allows localization of small neuroendocrine tumors during parenchymal-sparing pancreatic surgeryJoanna K Law, Vikesh K Singh, Mouen A Khashab, et al.
Annals of Surgery|August 27, 2019
Management of Locally Advanced Pancreatic Cancer: Results of an International Survey of Current PracticeBradley N Reames, Alex B Blair, Robert W Krell, et al.
Genetics|December 31, 2024
A Drosophila model of mucopolysaccharidosis IIIBBibhu Simkhada, Nestor O Nazario-Yepiz, Patrick S Freymuth, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|January 4, 2020
Acceptability of cardiac donation after circulatory determination of death: a survey of the Canadian publicKimia Honarmand, Jeanna Parsons Leigh, Claudio M Martin, et al.
Journal of Virology|October 12, 2023
4-Octyl itaconate reduces influenza A replication by targeting the nuclear export protein CRM1Pau Ribó-Molina, Hauke J Weiss, Balasubramanian Susma, et al.
Annals of Surgery|May 30, 2002
Endovascular repair of abdominal aortic aneurysms: risk stratified outcomesElliot L Chaikof, Peter H Lin, William T Brinkman, et al.
In Vivo (Athens, Greece)|December 25, 2017
Effect of Increased Intra-abdominal Pressure on Liver Histology and Hemodynamics: An Experimental StudyEfstathios A Antoniou, Evi Kairi, Georgios A Margonis, et al.
European Journal of Cancer (Oxford, England : 1990)|September 29, 2014
Phase I dose-escalation studies of SNX-5422, an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumoursJeffrey R Infante, Glen J Weiss, Suzanne Jones, et al.
Investigational New Drugs|July 21, 2017
Phase I dose escalation study of NMS-1286937, an orally available Polo-Like Kinase 1 inhibitor, in patients with advanced or metastatic solid tumorsGlen J Weiss, Gayle Jameson, Daniel D Von Hoff, et al.
Clinical & Experimental Metastasis|April 9, 2014
FN14 expression correlates with MET in NSCLC and promotes MET-driven cell invasionTimothy G Whitsett, Shannon P Fortin Ensign, Harshil D Dhruv, et al.
Pageof 307